Bergan Kdv Wealth Management, LLC Gsk PLC Transaction History

Bergan Kdv Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$40.23 - $47.74 $4,022 - $4,774	-100 Reduced 6.06%	1,551 $68,000
Q4 2021 Jan 28, 2022	BUY	$38.88 - $45.31 $3,888 - $4,531	100 Added 6.45%	1,651 $73,000
Q4 2020 Feb 04, 2021	BUY	$34.07 - $39.94 $1,737 - $2,036	51 Added 3.4%	1,551 $57,000
Q2 2020 Aug 13, 2020	SELL	$37.87 - $43.58 $1,931 - $2,222	-51 Reduced 3.29%	1,500 $61,000
Q4 2019 Feb 10, 2020	BUY	$42.0 - $48.25 $2,142 - $2,460	51 Added 3.4%	1,551 $73,000
Q3 2019 Nov 08, 2019	SELL	$40.46 - $43.52 $20,230 - $21,760	-500 Reduced 25.0%	1,500 $64,000
Q2 2019 Aug 12, 2019	SELL	$39.4 - $42.7 $11,820 - $12,810	-300 Reduced 13.04%	2,000 $80,000
Q3 2018 Nov 09, 2018	SELL	$39.75 - $42.69 $3,975 - $4,269	-100 Reduced 4.17%	2,300 $92,000
Q2 2018 Jul 23, 2018	BUY	$39.61 - $42.76 $95,064 - $102,624	2,400 New	2,400 $97,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.